ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 71 filers reported holding ALLOVIR INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,663 | +12.6% | 3,099 | +78.0% | 0.00% | – |
| Q2 2023 | $5,919 | +221.0% | 1,741 | +272.0% | 0.00% | – |
| Q1 2023 | $1,844 | -81.0% | 468 | -75.3% | 0.00% | – |
| Q4 2022 | $9,721 | -35.0% | 1,895 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $14,952 | +11.9% | 1,895 | -4.3% | 0.00% | – |
| Q1 2022 | $13,365 | -87.3% | 1,980 | -75.6% | 0.00% | -100.0% |
| Q4 2021 | $105,021 | -53.2% | 8,116 | -9.3% | 0.00% | -66.7% |
| Q3 2021 | $224,287 | +16.8% | 8,950 | -8.0% | 0.00% | 0.0% |
| Q2 2021 | $192,050 | -5.8% | 9,729 | +11.7% | 0.00% | 0.0% |
| Q1 2021 | $203,791 | -3.7% | 8,709 | +58.1% | 0.00% | 0.0% |
| Q4 2020 | $211,728 | +39.8% | 5,508 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $151,470 | – | 5,508 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $44,004,000 | 1.88% |
| GMT CAPITAL CORP | 2,758,846 | $21,767,000 | 1.35% |
| Regency Capital Management Inc.\DE | 75,010 | $592,000 | 0.73% |
| Redmile Group, LLC | 1,907,969 | $15,054,000 | 0.58% |
| Samsara BioCapital, LLC | 82,336 | $650,000 | 0.15% |
| Alkeon Capital Management | 4,923,104 | $38,843,000 | 0.13% |
| Woodline Partners LP | 1,087,093 | $8,577,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,625 | $612,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 44,987 | $355,000 | 0.07% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,634 | $9,023,000 | 0.07% |